View Financial HealthChemlite Innovation Berhad 配当と自社株買い配当金 基準チェック /26Chemlite Innovation Berhad配当を支払う会社であり、現在の利回りは4.67%で、収益によって十分にカバーされています。主要情報4.7%配当利回り-0.2%バイバック利回り総株主利回り4.4%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向36%最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Jul 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Share price has been volatile over the past 3 months (9.3% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM87.0m market cap, or US$21.3m).New Risk • May 25New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Dividend per share is over 12x cash flows per share. Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM138.0m market cap, or US$34.8m).Reported Earnings • May 20First quarter 2026 earnings released: EPS: RM0.002 (vs RM0.001 in 1Q 2025)First quarter 2026 results: EPS: RM0.002 (up from RM0.001 in 1Q 2025). Revenue: RM8.43m (down 11% from 1Q 2025). Net income: RM1.06m (up 91% from 1Q 2025). Profit margin: 13% (up from 5.9% in 1Q 2025). The increase in margin was driven by lower expenses.分析記事 • May 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)The market rallied behind Chemlite Innovation Berhad's ( KLSE:CLITE ) stock, leading do a rise in the share price after...お知らせ • Apr 22Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, MalaysiaReported Earnings • Mar 01Full year 2025 earnings released: EPS: RM0.01 (vs RM0.036 in FY 2024)Full year 2025 results: EPS: RM0.01 (down from RM0.036 in FY 2024). Revenue: RM41.6m (up 22% from FY 2024). Net income: RM5.42m (down 42% from FY 2024). Profit margin: 13% (down from 27% in FY 2024). The decrease in margin was driven by higher expenses.分析記事 • Nov 27Here's Why Chemlite Innovation Berhad (KLSE:CLITE) Has A Meaningful Debt BurdenWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Reported Earnings • Nov 25Third quarter 2025 earnings released: EPS: RM0.002 (vs RM0.005 in 3Q 2024)Third quarter 2025 results: EPS: RM0.002 (down from RM0.005 in 3Q 2024). Revenue: RM10.3m (up 20% from 3Q 2024). Net income: RM1.14m (down 55% from 3Q 2024). Profit margin: 11% (down from 29% in 3Q 2024). The decrease in margin was driven by higher expenses.分析記事 • Sep 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)Chemlite Innovation Berhad's ( KLSE:CLITE ) stock showed strength, with investors undeterred by its weak earnings...Reported Earnings • Aug 31Second quarter 2025 earnings released: EPS: RM0.002 (vs RM0.062 in 2Q 2024)Second quarter 2025 results: EPS: RM0.002 (down from RM0.062 in 2Q 2024). Revenue: RM8.91m (up 4.9% from 2Q 2024). Net income: RM821.0k (down 61% from 2Q 2024). Profit margin: 9.2% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses.分析記事 • Jul 11Is Chemlite Innovation Berhad (KLSE:CLITE) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Jun 03First quarter 2025 earnings released: EPS: RM0.001 (vs RM0.062 in 1Q 2024)First quarter 2025 results: EPS: RM0.001 (down from RM0.062 in 1Q 2024). Revenue: RM9.42m (up 11% from 1Q 2024). Net income: RM552.0k (down 74% from 1Q 2024). Profit margin: 5.9% (down from 25% in 1Q 2024). The decrease in margin was driven by higher expenses.お知らせ • Apr 29Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, MalaysiaBoard Change • Mar 26High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. COO & Executive Director Chee Heng is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.決済の安定と成長配当データの取得安定した配当: CLITEは配当の支払いを開始したばかりなので、配当金の支払いが安定しているかどうかを判断するのは時期尚早です。増加する配当: CLITEは配当の支払いを開始したばかりなので、配当金が増加するかどうかを判断するのは時期尚早です。 配当利回り対市場Chemlite Innovation Berhad 配当利回り対市場CLITE 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (CLITE)4.7%市場下位25% (MY)2.0%市場トップ25% (MY)5.4%業界平均 (Metals and Mining)1.7%アナリスト予想 (CLITE) (最長3年)n/a注目すべき配当: CLITEの配当金 ( 4.67% ) はMY市場の配当金支払者の下位 25% ( 2% ) よりも高くなっています。高配当: CLITEの配当金 ( 4.67% ) はMY市場の配当金支払者の上位 25% ( 5.38% ) と比較すると低いです。株主への利益配当収益カバレッジ: CLITEの 配当性向 ( 35.5% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: CLITEは高い 現金配当性向 ( 1299.2% ) のため、配当金の支払いはキャッシュフローで十分にカバーされていません。高配当企業の発掘7D1Y7D1Y7D1YMY 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/22 01:46終値2026/07/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Chemlite Innovation Berhad 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Jul 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Malaysian stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Share price has been volatile over the past 3 months (9.3% average weekly change). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM87.0m market cap, or US$21.3m).
New Risk • May 25New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. Dividend per share is over 12x cash flows per share. Dividend yield: 3.1% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 12x cash flows per share). Profit margins are more than 30% lower than last year (15% net profit margin). Market cap is less than US$100m (RM138.0m market cap, or US$34.8m).
Reported Earnings • May 20First quarter 2026 earnings released: EPS: RM0.002 (vs RM0.001 in 1Q 2025)First quarter 2026 results: EPS: RM0.002 (up from RM0.001 in 1Q 2025). Revenue: RM8.43m (down 11% from 1Q 2025). Net income: RM1.06m (up 91% from 1Q 2025). Profit margin: 13% (up from 5.9% in 1Q 2025). The increase in margin was driven by lower expenses.
分析記事 • May 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)The market rallied behind Chemlite Innovation Berhad's ( KLSE:CLITE ) stock, leading do a rise in the share price after...
お知らせ • Apr 22Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026Chemlite Innovation Berhad, Annual General Meeting, May 15, 2026, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, Malaysia
Reported Earnings • Mar 01Full year 2025 earnings released: EPS: RM0.01 (vs RM0.036 in FY 2024)Full year 2025 results: EPS: RM0.01 (down from RM0.036 in FY 2024). Revenue: RM41.6m (up 22% from FY 2024). Net income: RM5.42m (down 42% from FY 2024). Profit margin: 13% (down from 27% in FY 2024). The decrease in margin was driven by higher expenses.
分析記事 • Nov 27Here's Why Chemlite Innovation Berhad (KLSE:CLITE) Has A Meaningful Debt BurdenWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Reported Earnings • Nov 25Third quarter 2025 earnings released: EPS: RM0.002 (vs RM0.005 in 3Q 2024)Third quarter 2025 results: EPS: RM0.002 (down from RM0.005 in 3Q 2024). Revenue: RM10.3m (up 20% from 3Q 2024). Net income: RM1.14m (down 55% from 3Q 2024). Profit margin: 11% (down from 29% in 3Q 2024). The decrease in margin was driven by higher expenses.
分析記事 • Sep 05Weak Statutory Earnings May Not Tell The Whole Story For Chemlite Innovation Berhad (KLSE:CLITE)Chemlite Innovation Berhad's ( KLSE:CLITE ) stock showed strength, with investors undeterred by its weak earnings...
Reported Earnings • Aug 31Second quarter 2025 earnings released: EPS: RM0.002 (vs RM0.062 in 2Q 2024)Second quarter 2025 results: EPS: RM0.002 (down from RM0.062 in 2Q 2024). Revenue: RM8.91m (up 4.9% from 2Q 2024). Net income: RM821.0k (down 61% from 2Q 2024). Profit margin: 9.2% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses.
分析記事 • Jul 11Is Chemlite Innovation Berhad (KLSE:CLITE) A Risky Investment?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Jun 03First quarter 2025 earnings released: EPS: RM0.001 (vs RM0.062 in 1Q 2024)First quarter 2025 results: EPS: RM0.001 (down from RM0.062 in 1Q 2024). Revenue: RM9.42m (up 11% from 1Q 2024). Net income: RM552.0k (down 74% from 1Q 2024). Profit margin: 5.9% (down from 25% in 1Q 2024). The decrease in margin was driven by higher expenses.
お知らせ • Apr 29Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025Chemlite Innovation Berhad, Annual General Meeting, May 29, 2025, at 10:30 Singapore Standard Time. Location: iconic 1 & 2, iconic hotel, 71 jalan icon city, icon city, 14000 bukit mertajam, penang, Malaysia
Board Change • Mar 26High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. COO & Executive Director Chee Heng is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.